Showing results (91-100 of 136) with videos related to
Sort By:
Pageof 14
Breast Cancer Research and Treatment|April 29, 2017
Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitorsKunal C Kadakia, Kelley M Kidwell, Nicholas J Seewald, et al.Journal of Biopharmaceutical Statistics|November 11, 2008
A mixture model approach in gene-gene and gene-environmental interactions for binary phenotypesLang Li, Menggang Yu, Robarge D Jason, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 14, 2002
Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoinJae-Gook Shin, Ji-Young Park, Min-Jung Kim, et al.Pharmacotherapy|November 26, 2008
Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunctionJames E Tisdale, Brian R Overholser, Kevin M Sowinski, et al.Pharmacotherapy|July 27, 2010
Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes studyRolf P Kreutz, Eric J Stanek, Ronald Aubert, et al.Current Therapeutic Research, Clinical and Experimental|October 30, 2014
Substantial effect of efavirenz monotherapy on bilirubin levels in healthy volunteersIngrid F Metzger, Troy C Quigg, Noam Epstein, et al.Journal of Clinical Pharmacology|November 3, 2011
Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunctionJames E Tisdale, Brian R Overholser, Heather A Wroblewski, et al.Breast Cancer Research and Treatment|September 25, 2007
Association of polymorphisms of angiogenesis genes with breast cancerBryan P Schneider, Milan Radovich, George W Sledge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancerN Lynn Henry, Faouzi Azzouz, Zereunesay Desta, et al.Drug Metabolism and Pharmacokinetics|April 8, 2016
Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteersDoo-Yeoun Cho, Joan H Q Shen, Suzanne M Lemler, et al.Pageof 14